Eli Lilly Expands Its In Vivo Ambitions, Acquiring Cell Therapy Startup Orna for up to $2.4B Read More February 9, 2026
Europe’s Promising (But Rocky) Path to Embracing Single-Use Device Reprocessing Read More February 9, 2026
Clinical Trial Win Bolsters Blockbuster Prospects for Roivant Rare Disease Drug Licensed From Pfizer Read More February 8, 2026
It Doesn’t All Have to Be Doom and Gloom for Rural Hospitals – A Blueprint for Improving Cost Structures Read More February 8, 2026